Send to

Choose Destination
Mol Cancer. 2018 Apr 27;17(1):85. doi: 10.1186/s12943-018-0835-8.

Telomerase regulation by the long non-coding RNA H19 in human acute promyelocytic leukemia cells.

Author information

INSERM UMR-S 1007, Cellular Homeostasis and Cancer, Paris, France.
Paris-Descartes University, Paris Sorbonne Cité, Paris, France.
Paris-Sud University, Paris-Saclay University, Orsay, France.
Cancer and Metabolism Laboratory, Faculty of Medicine, Saint-Joseph University, Beirut, Lebanon.
Present address: Bristol-Myers Squibb (China) Investment Co. Ltd., Shanghai, 200040, People's Republic of China.
INSERM U 908, University Lille 1, Villeneuve d'Ascq, France.
INSERM UMR-S 1007, Cellular Homeostasis and Cancer, Paris, France.
Paris-Descartes University, Paris Sorbonne Cité, Paris, France.
Paris-Sud University, Paris-Saclay University, Orsay, France.
INSERM UMR-S 1007, Paris-Descartes University, 45 rue des Saints-Pères, 75006, Paris, France.



Since tumor growth requires reactivation of telomerase (hTERT), this enzyme is a challenging target for drug development. Therefore, it is of great interest to identify telomerase expression and activity regulators. Retinoids are well-known inducers of granulocytic maturation associated with hTERT repression in acute promyelocytic leukemia (APL) blasts. In a maturation-resistant APL cell line, we have previously identified a new pathway of retinoid-induced hTERT transcriptional repression independent of differentiation. Furthermore, we reported the isolation of a cell variant resistant to this repression. Those cell lines could serve as unique tools to identify new telomerase regulators.


Using a microarray approach we identified the long non-coding RNA, H19 as a potential candidate playing a role in telomerase regulation. Expression of H19, hTERT, and hTR were examined by quantitative reverse transcriptase polymerase chain reaction (qRT-PCR). Telomerase activity was quantified by quantitative telomeric repeats amplification protocol (qTRAP). In vitro and in vivo assays were performed to investigate H19 function on telomerase expression and activity.


We showed both in retinoid-treated cell lines and in APL patient cells an inverse relationship between the expression of H19 and the expression and activity of hTERT. Exploring the mechanistic link between H19 and hTERT regulation, we showed that H19 is able to impede telomerase function by disruption of the hTERT-hTR interaction.


This study identifies a new way of telomerase regulation through H19's involvement and thereby reveals a new function for this long non-coding RNA that can be targeted for therapeutic purpose.


Acute promyelocytic leukemia; H19 long non-coding RNA; Retinoids; Telomerase; hTERT; hTR

Supplemental Content

Full text links

Icon for BioMed Central Icon for PubMed Central
Loading ...
Support Center